bufalin and Fibrosis

bufalin has been researched along with Fibrosis in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	2 (100.00)	2.80

Authors

Authors	Studies
Gao, R; Lv, Y; Wei, X; Xu, Y; Yang, C; Zou, S	1
Alexander, KM; Bähre, H; Bär, C; Batkai, S; Beaumont, J; Bock, K; Braesen, JH; Brandenberger, C; Dangwal, S; Diez, J; Do, QT; Fiedler, J; Fisch, S; Foinquinos, A; Geffers, R; González, A; Grote-Levi, L; Hobuß, L; Janssen-Peters, H; José, GS; Jung, M; Just, A; Kaever, V; Kenneweg, F; Kleemiss, F; Kreutzer, FP; Leonardy, J; Liao, R; López, B; Müller, DN; Ngoy, S; Pfanne, A; Piccoli, MT; Ravassa, S; Remke, J; Samolovac, S; Santer, L; Scherf, K; Schimmel, K; Schmitz, J; Thum, T; Wertheim, BM; Wilck, N; Xiao, K; Zimmer, K	1

Studies

Gao, R; Lv, Y; Wei, X; Xu, Y; Yang, C; Zou, S

Alexander, KM; Bähre, H; Bär, C; Batkai, S; Beaumont, J; Bock, K; Braesen, JH; Brandenberger, C; Dangwal, S; Diez, J; Do, QT; Fiedler, J; Fisch, S; Foinquinos, A; Geffers, R; González, A; Grote-Levi, L; Hobuß, L; Janssen-Peters, H; José, GS; Jung, M; Just, A; Kaever, V; Kenneweg, F; Kleemiss, F; Kreutzer, FP; Leonardy, J; Liao, R; López, B; Müller, DN; Ngoy, S; Pfanne, A; Piccoli, MT; Ravassa, S; Remke, J; Samolovac, S; Santer, L; Scherf, K; Schimmel, K; Schmitz, J; Thum, T; Wertheim, BM; Wilck, N; Xiao, K; Zimmer, K

Other Studies

2 other study(ies) available for bufalin and Fibrosis

Article	Year
Bufalin reduces myocardial infarction-induced myocardial fibrosis and improves cardiac function by inhibiting the NLRP3/IL-1β signalling pathway. Clinical and experimental pharmacology & physiology, 2023, Volume: 50, Issue:8 Topics: Animals; Disease Models, Animal; Fibrosis; Inflammasomes; Interleukin-1beta; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; NLR Family, Pyrin Domain-Containing 3 Protein; Stroke Volume; Sulfonamides; Ventricular Function, Left	2023
Natural Compound Library Screening Identifies New Molecules for the Treatment of Cardiac Fibrosis and Diastolic Dysfunction. Circulation, 2020, 03-03, Volume: 141, Issue:9 Topics: Amaryllidaceae Alkaloids; Animals; Apoptosis; Bufanolides; Cardiomyopathies; Cardiovascular Agents; Cell Proliferation; Cells, Cultured; Diastole; Disease Models, Animal; Extracellular Matrix; Fibroblasts; Fibrosis; High-Throughput Screening Assays; Humans; Hypertension; Male; Mice, Inbred C57BL; MicroRNAs; Myocardium; Phenanthridines; Rats, Inbred Dahl; Selenoprotein P; Ventricular Function, Left	2020

Article

Year

Bufalin reduces myocardial infarction-induced myocardial fibrosis and improves cardiac function by inhibiting the NLRP3/IL-1β signalling pathway.

Clinical and experimental pharmacology & physiology, 2023, Volume: 50, Issue:8

Topics: Animals; Disease Models, Animal; Fibrosis; Inflammasomes; Interleukin-1beta; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; NLR Family, Pyrin Domain-Containing 3 Protein; Stroke Volume; Sulfonamides; Ventricular Function, Left

2023

Natural Compound Library Screening Identifies New Molecules for the Treatment of Cardiac Fibrosis and Diastolic Dysfunction.

Circulation, 2020, 03-03, Volume: 141, Issue:9

Topics: Amaryllidaceae Alkaloids; Animals; Apoptosis; Bufanolides; Cardiomyopathies; Cardiovascular Agents; Cell Proliferation; Cells, Cultured; Diastole; Disease Models, Animal; Extracellular Matrix; Fibroblasts; Fibrosis; High-Throughput Screening Assays; Humans; Hypertension; Male; Mice, Inbred C57BL; MicroRNAs; Myocardium; Phenanthridines; Rats, Inbred Dahl; Selenoprotein P; Ventricular Function, Left

2020